Preimmunization with a heat-killed preparation of Mycobacterium vaccae enhances fear extinction in the fear-potentiated startle paradigm

Brain, Behavior, and Immunity

Volumn 66, Issue , 2017, Pages 70-84

  Fox, James H ^a   Hassell, James E ^a   Siebler, Philip H ^a   Arnold, Mathew R ^a   Lamb, Andrew K ^a   Smith, David G ^a   Day, Heidi E W ^a   Smith, Tessa M ^a   Simmerman, Emma M ^a   Outzen, Alexander A ^a   Holmes, Kaley S ^a   Brazell, Christopher J ^a   Lowry, Christopher A ^a,b,c,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Mental Illness Research Education and Clinical Center   (United States)

^d Military and Veteran Microbiome Consortium of Research and Education (MVM CORE)   (United States)

Author keywords

Acoustic startle; Actinobacteria; Fear potentiated startle; htr1a; Mycobacteria; Mycobacterium vaccae; Organic cation transporter 3; slc22a3; slc6a4; tph2

Indexed keywords

MESSENGER RNA; SEROTONIN; BACTERIAL VACCINE; INACTIVATED VACCINE; ORGANIC CATION TRANSPORTER; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, RAT; SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 3; TPH2 PROTEIN, RAT; TRYPTOPHAN HYDROXYLASE;

ACOUSTIC REFLEX; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FEAR-POTENTIATED STARTLE TEST; GENE; GENE EXPRESSION; HEAT TREATMENT; HTR1A GENE; IMMUNIZATION; MALE; MEDIAN RAPHE NUCLEUS; MYCOBACTERIUM VACCAE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SLC22A3 GENE; SLC6A4 GENE; TPH2 GENE; ANIMAL; BRAIN; CONDITIONED REFLEX; FEAR; IMMUNOLOGY; MENTAL STRESS; METABOLISM; MYCOBACTERIUM; REINFORCEMENT; SPRAGUE DAWLEY RAT; STARTLE REFLEX;

ANIMALS; BACTERIAL VACCINES; BRAIN; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; FEAR; IMMUNIZATION; MALE; MYCOBACTERIUM; ORGANIC CATION TRANSPORT PROTEINS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; REFLEX, STARTLE; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL; TRYPTOPHAN HYDROXYLASE; VACCINES, INACTIVATED;

EID: 85029419301     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2017.08.014     Document Type: Article

References (75)

1. Abrams, J.K., Johnson, P.L., Hollis, J.H., Lowry, C.A., Anatomic and functional topography of the dorsal raphe nucleus. Ann. N. Y. Acad. Sci. 1018 (2004), 46–57.
2. Almada, R.C., Borelli, K.G., Albrechet-Souza, L., Brandao, M.L., Serotonergic mechanisms of the median raphe nucleus-dorsal hippocampus in conditioned fear: output circuit involves the prefrontal cortex and amygdala. Behav. Brain Res. 203 (2009), 279–287.
3. Baganz, N.L., Horton, R., Martin, K., Holmes, A., Daws, L.C., Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J. Neurosci. 30 (2010), 15185–15195.
4. Baratta, M.V., Kodandaramaiah, S.B., Monahan, P.E., Yao, J., Weber, M.D., Lin, P.A., Gisabella, B., Petrossian, N., Amat, J., Kim, K., Yang, A., Forest, C.R., Boyden, E.S., Goosens, K.A., Stress enables reinforcement-elicited serotonergic consolidation of fear memory. Biol. Psychiatry 79 (2016), 814–822.
5. Bazzi, S., Modjtahedi, H., Mudan, S., Akle, C., Bahr, G.M., Analysis of the immunomodulatory properties of two heat-killed mycobacterial preparations in a human whole blood model. Immunobiology 220 (2015), 1293–1304.
6. Bocchio, M., McHugh, S.B., Bannerman, D.M., Sharp, T., Capogna, M., Serotonin, amygdala and fear: assembling the puzzle. Front Neural Circuits, 10, 2016, 24.
7. Borelli, K.G., Gargaro, A.C., dos Santos, J.M., Brandao, M.L., Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning. Neurosci. Lett. 387 (2005), 105–110.
8. Bouton, M.E., Context and behavioral processes in extinction. Learn Mem. 11 (2004), 485–494.
9. Bouwknecht, J.A., Spiga, F., Staub, D.R., Hale, M.W., Shekhar, A., Lowry, C.A., Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res. Bull. 72 (2007), 32–43.
10. Camara, R.J., Gander, M.L., Begre, S., von Kanel, R., Swiss Inflammatory Bowel Disease Cohort Study Group, Post-traumatic stress in Crohn's disease and its association with disease activity. Frontline Gastroenterol. 2 (2011), 2–9.
11. Davis, M., Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav. Neurosci. 100 (1986), 814–824.
12. Day, H.E., Akil, H., Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology 63 (1996), 207–218.
13. Doenni, V.M., Song, C.M., Hill, M.N., Pittman, Q.J., Early-life inflammation with LPS delays fear extinction in adult rodents. Brain, Behav., Immun. 63 (2017), 176–185.
14. Eraly, S.A.C.M., Nievergelt, A.X., Maihofer, D.A., Barkauskas, N., Biswas, A., Agorastos, D.T., O'Connor, D.G., Baker Marine Resiliency Study, T., Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 71 (2014), 423–431.
15. Falls, W.A., Fox, J.H., MacAulay, C.M., Voluntary exercise improves both learning and consolidation of cued conditioned fear in C57 mice. Behav. Brain Res. 207 (2010), 321–331.
16. Fanselow, M.S., LeDoux, J.E., Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron 23 (1999), 229–232.
17. Fernandez, S.P., Cauli, B., Cabezas, C., Muzerelle, A., Poncer, J.C., Gaspar, P., Multiscale single-cell analysis reveals unique phenotypes of raphe 5-HT neurons projecting to the forebrain. Brain Struct. Funct. 221 (2016), 4007–4025.
18. Fox, J.H., Hammack, S.E., Falls, W.A., Exercise is associated with reduction in the anxiogenic effect of mCPP on acoustic startle. Behav. Neurosci. 122 (2008), 943–948.
19. Gardner, K.L., Hale, M.W., Lightman, S.L., Plotsky, P.M., Lowry, C.A., Adverse early life experience and social stress during adulthood interact to increase serotonin transporter mRNA expression. Brain Res. 1305 (2009), 47–63.
20. Gardner, K.L., Hale, M.W., Oldfield, S., Lightman, S.L., Plotsky, P.M., Lowry, C.A., Adverse experience during early life and adulthood interact to elevate tph2 mRNA expression in serotonergic neurons within the dorsal raphe nucleus. Neuroscience 163 (2009), 991–1001.
21. 1b-adrenergic receptor mRNA in the rat raphe nuclei. Biol. Psychiatry 57 (2005), 559–568.
22. Grillon, C., Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology 199 (2008), 421–437.
23. Grillon, C., Morgan, C.A. 3rd, Davis, M., Southwick, S.M., Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol. Psychiatry 44 (1998), 1027–1036.
24. Grubbs, F.E., Procedures for detecting outlying observations in samples. Technometrics 11 (1969), 1–21.
25. Guo, M., Liu, T., Guo, J.C., Jiang, X.L., Chen, F., Gao, Y.S., Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pac. J. Trop. Med. 5 (2012), 323–325.
26. Hale, M.W., Bouwknecht, J.A., Spiga, F., Shekhar, A., Lowry, C.A., Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex. Brain Res. Bull. 71 (2006), 174–182.
27. Hannon, J., Hoyer, D., Molecular biology of 5-HT receptors. Behav. Brain Res. 195 (2008), 198–213.
28. Hassell, J. Jr, Yamashita, P., Johnson, P., Zangrossi, H. Jr, Shekhar, A., Lowry, C., Stress, panic, and central serotonergic inhibition. Fink, G., (eds.) Stress: Neuroendocrinology and Neurobiology, 2017, Elsevier, Amsterdam, 153–164.
29. Hernandez-Pando, R., Aguilar, D., Orozco, H., Cortez, Y., Brunet, L.R., Rook, G.A., Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis. Clin. Vacc. Immunol.: CVI 15 (2008), 1730–1736.
30. Hill, J.E., Makky, K., Shrestha, L., Hillard, C.J., Gasser, P.J., Natural and synthetic corticosteroids inhibit uptake 2-mediated transport in CNS neurons. Physiol. Behav. 104 (2011), 306–311.
31. Hodes, G.E., Pfau, M.L., Leboeuf, M., Golden, S.A., Christoffel, D.J., Bregman, D., Rebusi, N., Heshmati, M., Aleyasin, H., Warren, B.L., Lebonte, B., Horn, S., Lapidus, K.A., Stelzhammer, V., Wong, E.H., Bahn, S., Krishnan, V., Bolanos-Guzman, C.A., Murrough, J.W., Merad, M., Russo, S.J., Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 16136–16141.
32. Hoge, E.A., Brandstetter, K., Moshier, S., Pollack, M.H., Wong, K.K., Simon, N.M., Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress. Anxiety 26 (2009), 447–455.
33. Jensen, P., Farago, A.F., Awatramani, R.B., Scott, M.M., Deneris, E.S., Dymecki, S.M., Redefining the serotonergic system by genetic lineage. Nat. Neurosci. 11 (2008), 417–419.
34. Johnson, P.L., Molosh, A., Fitz, S.D., Arendt, D., Deehan, G.A., Federici, L.M., Bernabe, C., Engleman, E.A., Rodd, Z.A., Lowry, C.A., Shekhar, A., Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning. Pharmacol., Biochem. Behav. 138 (2015), 174–179.
35. Jovanovic, T., Norrholm, S.D., Blanding, N.Q., Davis, M., Duncan, E., Bradley, B., Ressler, K.J., Impaired fear inhibition is a biomarker of PTSD but not depression. Depress. Anxiety 27 (2010), 244–251.
36. Jovanovic, T., Norrholm, S.D., Fennell, J.E., Keyes, M., Fiallos, A.M., Myers, K.M., Davis, M., Duncan, E.J., Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Research 167 (2009), 151–160.
37. Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., Walters, E.E., Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005), 617–627.
38. Kessler, R.C., Sonnega, A., Bromet, E., Hughes, M., Nelson, C.B., Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 52 (1995), 1048–1060.
39. Klaus, F., Paterna, J.C., Marzorati, E., Sigrist, H., Gotze, L., Schwendener, S., Bergamini, G., Jehli, E., Azzinnari, D., Fuertig, R., Fontana, A., Seifritz, E., Pryce, C.R., Differential effects of peripheral and brain tumor necrosis factor on inflammation, sickness, emotional behavior and memory in mice. Brain, Behav., Immun. 58 (2016), 310–326.
40. LaBar, K.S., Gatenby, J.C., Gore, J.C., LeDoux, J.E., Phelps, E.A., Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20 (1998), 937–945.
41. Lee, H.J., Lee, M.S., Kang, R.H., Kim, H., Kim, S.D., Kee, B.S., Kim, Y.H., Kim, Y.K., Kim, J.B., Yeon, B.K., Oh, K.S., Oh, B.H., Yoon, J.S., Lee, C., Jung, H.Y., Chee, I.S., Paik, I.H., Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress. Anxiety 21 (2005), 135–139.
42. Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, D.H., Murphy, D.L., Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996), 1527–1531.
43. Liang, K.C., Melia, K.R., Miserendino, M.J., Falls, W.A., Campeau, S., Davis, M., Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J. Neurosci. 12 (1992), 2303–2312.
44. Line, S.J., Barkus, C., Rawlings, N., Jennings, K., McHugh, S., Sharp, T., Bannerman, D.M., Reduced sensitivity to both positive and negative reinforcement in mice over-expressing the 5-hydroxytryptamine transporter. Eur. J. Neurosci. 40 (2014), 3735–3745.
45. Lowry, C.A., Hollis, J.H., de Vries, A., Pan, B., Brunet, L.R., Hunt, J.R., Paton, J.F., van Kampen, E., Knight, D.M., Evans, A.K., Rook, G.A., Lightman, S.L., Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience 146 (2007), 756–772.
46. Lowry, C.A., Johnson, P.L., Hay-Schmidt, A., Mikkelsen, J., Shekhar, A., Modulation of anxiety circuits by serotonergic systems. Stress 8 (2005), 233–246.
47. Lukkes, J.L., Kopelman, J.M., Donner, N.C., Hale, M.W., Lowry, C.A., Development x environment interactions control TPH2 mRNA expression. Neuroscience 237 (2013), 139–150.
48. Maier, S.F., Behavioral control blunts reactions to contemporaneous and future adverse events: medial prefrontal cortex plasticity and a corticostriatal network. Neurobiol. Stress 1 (2015), 12–22.
49. Maier, S.F., Amat, J., Baratta, M.V., Paul, E., Watkins, L.R., Behavioral control, the medial prefrontal cortex, and resilience. Dial. Clin. Neurosci. 8 (2006), 397–406.
50. Maier, S.F., Watkins, L.R., Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 29 (2005), 829–841.
51. Merikangas, K.R., He, J.P., Burstein, M., Swendsen, J., Avenevoli, S., Case, B., Georgiades, K., Heaton, L., Swanson, S., Olfson, M., Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J. Am. Acad. Child Adolesc. Psychiatry 50 (2011), 32–45.
52. Norrholm, S.D., Jovanovic, T., Olin, I.W., Sands, L.A., Karapanou, I., Bradley, B., Ressler, K.J., Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity. Biol. Psychiatry 69 (2011), 556–563.
53. O'Brien, M.E., Anderson, H., Kaukel, E., O'Byrne, K., Pawlicki, M., Von Pawel, J., Reck, M., Group, S.-O.-S., SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann. Oncol. 15 (2004), 906–914.
54. O'Donovan, A., Cohen, B.E., Seal, K.H., Bertenthal, D., Margaretten, M., Nishimi, K., Neylan, T.C., Elevated risk for autoimmune disorders in Iraq and Afghanistan veterans with posttraumatic stress disorder. Biol. Psychiatry 77 (2015), 365–374.
55. 3H]5-hydroxytryptamine. Neuroscience 6 (1981), 115–138.
56. Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates. 1998, Academic Press, San Diego.
57. Reber, S.O., Siebler, P.H., Donner, N.C., Morton, J.T., Smith, D.G., Kopelman, J.M., Lowe, K.R., Wheeler, K.J., Fox, J.H., Hassell, J.E. Jr., Greenwood, B.N., Jansch, C., Lechner, A., Schmidt, D., Uschold-Schmidt, N., Fuchsl, A.M., Langgartner, D., Walker, F.R., Hale, M.W., Lopez Perez, G., Van Treuren, W., Gonzalez, A., Halweg-Edwards, A.L., Fleshner, M., Raison, C.L., Rook, G.A., Peddada, S.D., Knight, R., Lowry, C.A., Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E3130–E3139.
58. Risbrough, V.B., Geyer, M.A., Anxiogenic treatments do not increase fear-potentiated startle in mice. Biol. Psychiatry 57 (2005), 33–43.
59. Russo, A.S., Parsons, R.G., Acoustic startle response in rats predicts inter-individual variation in fear extinction. Neurobiol. Learn. Mem. 139 (2017), 157–164.
60. Santini, E., Muller, R.U., Quirk, G.J., Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J. Neurosci. 21 (2001), 9009–9017.
61. Sidor, M.M., Amath, A., MacQueen, G., Foster, J.A., A developmental characterization of mesolimbocortical serotonergic gene expression changes following early immune challenge. Neuroscience 171 (2010), 734–746.
62. Silva, R.C., Cruz, A.P., Avanzi, V., Landeira-Fernandez, J., Brandao, M.L., Distinct contributions of median raphe nucleus to contextual fear conditioning and fear-potentiated startle. Neural Plast. 9 (2002), 233–247.
63. Sommershof, A., Aichinger, H., Engler, H., Adenauer, H., Catani, C., Boneberg, E.M., Elbert, T., Groettrup, M., Kolassa, I.T., Substantial reduction of naive and regulatory T cells following traumatic stress. Brain, Behav., Immun. 23 (2009), 1117–1124.
64. Spannuth, B.M., Hale, M.W., Evans, A.K., Lukkes, J.L., Campeau, S., Lowry, C.A., Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle. Neuroscience 179 (2011), 104–119.
65. Swerdlow, N.R., Britton, K.T., Koob, G.F., Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9–41). Neuropsychopharmacology 2 (1989), 285–292.
66. Swerdlow, N.R., Geyer, M.A., Vale, W.W., Koob, G.F., Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology 88 (1986), 147–152.
67. Tanielian, T., Haycox, L.H., Schell, T.L., Marshall, G.N., Burnam, M.A., Eibner, C., Karney, B.R., Meredith, L.S., Ringel, J.S., Vaiana, M.E., Invisible wounds of war. Summary and recommendations for addressing psychological and cognitive injuries. 2008, DTIC Document.
68. Thanellou, A., Green, J.T., Spontaneous recovery but not reinstatement of the extinguished conditioned eyeblink response in the rat. Behav. Neurosci. 125 (2011), 613–625.
69. VanElzakker, M.B., Dahlgren, M.K., Davis, F.C., Dubois, S., Shin, L.M., From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders. Neurobiol. Learn. Mem. 113 (2014), 3–18.
70. Walker, D.L., Davis, M., Involvement of NMDA receptors within the amygdala in short- versus long-term memory for fear conditioning as assessed with fear-potentiated startle. Behav. Neurosci. 114 (2000), 1019–1033.
71. Wellman, C.L., Izquierdo, A., Garrett, J.E., Martin, K.P., Carroll, J., Millstein, R., Lesch, K.P., Murphy, D.L., Holmes, A., Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 27 (2007), 684–691.
72. Wylie, C.J., Hendricks, T.J., Zhang, B., Wang, L., Lu, P., Leahy, P., Fox, S., Maeno, H., Deneris, E.S., Distinct transcriptomes define rostral and caudal serotonin neurons. J. Neurosci. 30 (2010), 670–684.
73. Young, M., Howell, L., Interleukin-6 as a peripheral fear signal and a regulator of fear memory maintenance. Neuropsychopharmacology, 2015, S106–S271.
74. Zanoveli, J.M., Carvalho, M.C., Cunha, J.M., Brandao, M.L., Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: an in vivo microdialysis study. Brain Res. 1294 (2009), 106–115.
75. Zuany-Amorim, C., Sawicka, E., Manlius, C., Le Moine, A., Brunet, L.R., Kemeny, D.M., Bowen, G., Rook, G., Walker, C., Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8 (2002), 625–629.